Erin Resources Ltd Share Price Australian S.E.
Equities
AU000000ERI2
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- AUD | - |
|
07/05 | Argent BioPharma Reports CFO Appointment | MT |
07/05 | Argent BioPharma shares begin trading on OTCQB Venture Market | AN |
Sales 2022 | 47.32L 31.42L 26Cr | Sales 2023 | 33.88L 22.49L 19Cr | Capitalization | 1.68Cr 1.11Cr 93Cr |
---|---|---|---|---|---|
Net income 2022 | -2Cr -1.33Cr -110.92Cr | Net income 2023 | -2Cr -1.33Cr -110.92Cr | EV / Sales 2022 | 9.75 x |
Net Debt 2022 | 24.66L 16.37L 14Cr | Net Debt 2023 | 95.15L 63.17L 53Cr | EV / Sales 2023 | 7.75 x |
P/E ratio 2022 |
-2.02
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 9.44% |
Managers | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 21/05/21 |
Yifat Steuer
COO | Chief Operating Officer | 53 | 04/22/04 |
Nadya Lisovoder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 21/05/21 |
Director/Board Member | - | 01/23/01 | |
Daniel Robinson
BRD | Director/Board Member | - | 01/12 |
1st Jan change | Capi. | |
---|---|---|
+34.14% | 586.78Cr | |
-30.04% | 371.38Cr | |
+1.55% | 316.72Cr | |
-22.68% | 270.77Cr | |
-8.17% | 235.67Cr | |
+42.02% | 188.73Cr | |
+45.22% | 149.53Cr | |
-12.58% | 143.55Cr | |
-27.42% | 132.07Cr |